ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,161Medicare Part D Prescriptions Filled, Including Refills

Rank: 496 out of 1107

$473K Total Retail Price of All Prescriptions

Rank: 405 out of 1107

212 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 212 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 212 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 5,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 288 252 1 3
OMEPRAZOLE 273 226 2 4
HYDROCODONE-ACETAMINOPHEN 214 116 S3 3 1
LISINOPRIL 172 138 4 2
SERTRALINE HCL 152 122 5 20
CARVEDILOL 127 121 6 27
DONEPEZIL HCL 120 119 7 32
NAMENDA 119 119 8 42
LOVASTATIN 114 91 9 55
METFORMIN HCL 112 90 10 8
METOPROLOL TARTRATE 109 103 11 10
ADVAIR DISKUS 105 48 12 54
WARFARIN SODIUM 105 104 12 15
NOVOLOG FLEXPEN 103 96 14 230
GABAPENTIN 99 74 15 9
FLUTICASONE PROPIONATE 95 65 16 38
POTASSIUM CHLORIDE 93 93 17 14
LANTUS SOLOSTAR 92 81 18 129
RANITIDINE HCL 92 42 18 21
JANUVIA 90 77 20 60
CRESTOR 85 70 21 23
MELOXICAM 84 29 22 25
BENAZEPRIL HCL 82 64 23 86
AMLODIPINE BESYLATE 79 61 24 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 71 24 24
ATORVASTATIN CALCIUM 74 39 26 13
SIMVASTATIN 69 51 27 5
MUPIROCIN 61 55 28 161
DIVALPROEX SODIUM 60 49 29 96
METOPROLOL SUCCINATE 60 39 29 16
NAPROXEN 59 20 31 80
SPIRIVA 58 41 32 57
VENTOLIN HFA 58 21 32 97
CYMBALTA 58 35 32 50
ISOSORBIDE MONONITRATE ER 57 55 35 34
HYDRALAZINE HCL 56 42 36 99
DILTIAZEM ER 54 46 37 139
NATEGLINIDE 54 48 37 279
TRIAMTERENE-HCTZ 52 44 39 62
CITALOPRAM HBR 51 30 40 17
ALLOPURINOL 51 40 40 36
CEPHALEXIN 50 39 42 81
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 40 42 88
PROMETHAZINE HCL 50 41 R 42 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.